CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · STOCK OPTION (RIGHT TO BUY) | +22,500 | 22,500 | ||
| 2021-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · RESTRICTED STOCK UNITS | +3,750 | 3,750 | ||
| 2021-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Grant or award · STOCK OPTION (RIGHT TO BUY) | +97,725 | 97,725 | ||
| 2021-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Grant or award · RESTRICTED STOCK UNITS | +16,288 | 16,288 | ||
| 2021-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Grant or award · STOCK OPTION (RIGHT TO BUY) | +30,900 | 30,900 | ||
| 2021-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Grant or award · RESTRICTED STOCK UNITS | +5,150 | 5,150 | ||
| 2021-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Grant or award · STOCK OPTION (RIGHT TO BUY) | +18,750 | 18,750 | ||
| 2021-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Grant or award · RESTRICTED STOCK UNITS | +3,125 | 3,125 | ||
| 2021-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Grant or award · STOCK OPTION (RIGHT TO BUY) | +22,500 | 22,500 | ||
| 2021-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Grant or award · RESTRICTED STOCK UNITS | +3,750 | 3,750 | ||
| 2020-12-09 | Jordan Maybelle Director | Grant or award · STOCK OPTION (RIGHT TO BUY) | +14,307 | 14,307 | ||
| 2020-12-09 | Mills C Randal Director | Grant or award · STOCK OPTION (RIGHT TO BUY) | +14,307 | 14,307 | ||
| 2020-12-09 | Makes Brigid Director | Grant or award · STOCK OPTION (RIGHT TO BUY) | +14,307 | 14,307 | ||
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Conversion | +4,062,451 | 4,062,451 | ||
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Option exercise | +7,655 | $5.44 | $42K | 4,070,106 |
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Shares withheld for taxes | −2,451 | $5.44 | $13K | 4,067,655 |
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Purchase | +441,176 | $17.00 | $7.5M | 4,508,831 |
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Conversion · Series A Convertible Preferred Stock | −31,133,977 | 0 | ||
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Option exercise · Warrant | −7,655 | 0 | ||
| 2020-10-13 | LLOYD RONALD K. President and CEO | Conversion | +14,586 | 14,586 |
Page 16 of 17 · 330 trades